Pharmacolog and B. Braun Group intensify partnership
Pharmacolog AB, specialist in solutions enhancing safety during medication preparation, and B. Braun Group, one of the world´s leading manufacturers of medical devices and pharmaceutical products, today announced to intensify their partnership.
Pharmacolog's systems for quality control of prepared medication as well as B. Braun´s Safe Infusion Therapy portfolio will be combined into a solution for safe medication preparation and management. The comprehensive B. Braun portfolio of infusion solutions, admixture and delivery devices offers customers full flexibility for the complete scope of toxic and non-toxic drug admixtures. Pharmacolog´s unique DrugLog and PrepLog systems verify the identity and concentration of prepared drugs, thus raising medication safety.
The parties are working to establish a formal commercial partnership agreement regarding Pharmacolog's DrugLog and PrepLog systems with the perspective of a global roll-out. Already in 2018, Pharmacolog and B. Braun have started their cooperation on technology development and successfully launched DrugLog and PrepLog in the Spanish market.
Mats Högberg, CEO of Pharmacolog, comments: “We have carried out focused efforts to establish strategic partnerships with major international players and are very pleased to have formalized our work with one of the world's largest and most respected medtech companies. B. Braun has impressed a lot in terms of industry expertise and visionary thinking. This means significantly improved opportunities to offer Pharmacolog's unique system for safer drug management to a global market.”
Jürgen Stihl, Member of the Board of B. Braun’s division Hospital Care, comments: “This partnership will add unique value to our customers by bringing the process of medication preparation to an even higher level of safety through a final step quality control. Pharmacolog´s advanced technology combined with B. Braun’s medication management portfolio will help further reduce risks of medication errors and patient harm.”
About B. Braun
With over 64,000 employees in 64 countries, B. Braun is one of the world's leading manufacturers of medical devices and pharmaceutical products and services. Through constructive dialog, B. Braun develops high quality product systems and services that are both evolving and progressive – and in turn improves people's health around the world.
Pharmacolog AB provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Further information regarding the company is available at http://www.pharmacolog.com. The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on November 4th, 2021 at 12:00.